Brieflist

Centres of Excellence for Regulatory Science and Innovation (Grant)

Apply for funding to establish a Centre of Excellence for Regulatory Science and Innovation (CERSI) to address strategic regulatory science priorities through sustained programmes of research.

Read the official page on Find a grant ↗Start an application ↗ Get new grants like this

Funder
UK Research and Innovation, Medical Research Council
Where
🇬🇧 United Kingdom
Status
Closes 12 Jan 2027 · 53 days left
Opened
22 Sep 2026
Funding
£1–£20m per award
Who can apply
Most organisations
Topics
Health Science & research Innovation & technology

About this grant

Apply for funding to establish a Centre of Excellence for Regulatory Science and Innovation (CERSI) to address strategic regulatory science priorities through sustained programmes of research.You must be based at a UK research organisation eligible for Medical Research Council (MRC) funding.CERSIs will be funded for up to five years, your award will initially last for three years, with a further two years dependent on government spending review and budget allocation.We expect to fund four CERSIs.

You should contact MHRA to discuss fit of your application and its alignment with MHRA regulatory science priorities. See how to apply for more information.

Objectives

Demand management

Demand management is not being applied to this funding opportunity.

Aim

Through this funding opportunity, the MRC, Medicines and Healthcare products Regulatory Agency (MHRA) and the Office for Life Sciences (OLS), aim to establish four Centres of Excellence for Regulatory Science and Innovation (CERSIs) across the UK. Each CERSI will seek to address regulatory science areas of strategic importance to the UK, by bringing together expertise from:

academia

regulators

industry

healthcare providers

patients and public partners

devolved administrations and local regions

CERSIs will play a vital role in the UK regulatory innovation ecosystem by advancing regulatory science. This will help address regulatory challenges and uncertainties, enabling innovative healthcare products and solutions to reach patients safely and more efficiently.

CERSI aims

CERSIs will support the development of the evidence, methods and tools needed for future regulatory decision-making, while supporting their translation into regulatory practice. CERSIs will strengthen the UK’s position as a global leader in regulatory science and support safe, effective and timely patient access to healthcare innovation.

The research programmes delivered through CERSIs should address clear regulatory challenges, evidence gaps or emerging issues, with a credible pathway to informing regulatory:

policy

practice

tools

decision making

Creating national capability

The intention is to fund four centres that deliver research excellence while creating national capability in priority areas of regulatory science. Proposed centres should complement existing investments and infrastructure, connecting relevant expertise and capabilities from devolved administrations and local regions, creating added value that could not be achieved through a collection of separate research projects.

The CERSI initiative aims to generate broadly applicable regulatory science:

knowledge

methods

tools

standards

Research solely focused on an individual healthcare product without broad applicability is not in scope.

Adaptive portfolio to respond to emerging priorities

Regulatory science priorities are expected to evolve over the lifetime of the award. CERSI research programmes will therefore operate as an adaptive portfolio, informed by:

horizon scanning

engagement with regulators

researchers

patients

industry and other stakeholders

devolved administrations and local regions

oversight of the wider CERSI programme

Centres will be expected to respond to emerging regulatory science priorities in areas related to their CERSI theme, identified through CERSI governance arrangements. Where required, centres will adapt elements of their work programmes to address these priorities, while continuing to deliver their core objectives and maintaining scientific excellence.

UK CERSI model

UK CERSIs were initially established in 2025 by MHRA, OLS, Innovate UK and MRC following a recommendation in Professor McLean’s 2023 Pro-innovation Regulation of Technologies Review. CERSIs support the Life Sciences Sector Plan ambition for the UK to be a global leader in regulation by 2035. Seven pilot centres received one year of seed funding to test and develop new approaches to regulatory science research and collaboration across different themes.

Lessons learned have informed the design of an enhanced UK CERSI initiative. A key change is the provision of programme funding for up to five years, recognising that addressing complex regulatory science challenges requires sustained investment in:

knowledge

expertise

capability

partnerships

This longer-term funding model will support CERSIs to build enduring partnerships between the research community, regulators and wider stakeholders. This will provide a mechanism to identify, investigate and translate solutions to regulatory science challenges, that cannot be addressed through individual projects alone.

CERSIs are part of a …

Dates

Assessment process

We will assess your application using the following process.

Examination of applications

All applications will be examined to ensure they meet the eligibility criteria and scope of the funding opportunity. If your application is outside the scope, you will be advised by email, and we will not assess your application.

Panel

There will be no externally written expert review for this funding opportunity. All applications will be assessed by an independent expert panel, who will make a funding recommendation.

For more information on how we prioritise applications for funding please visit How we make decisions.

We will take a portfolio approach to funding the CERSIs and this means we expect to fund only one CERSI for each of the four CERSI strategic themes.

The funders will make the final funding decision.

Principles of assessment

We support the San Francisco declaration on research assessment and recognise the relationship between research assessment and research integrity.

Find out about the UKRI principles of assessment and decision making.

Using generative artificial intelligence (AI) in expert review

Generative AI may be used only for the purpose of language refinement during application assessment. When using generative AI to refine the language of a review, expert reviewers and panellists must ensure that:

no part of the application being assessed is entered into a generative AI tool

no personal information from the application is disclosed

generative AI is not tasked with understanding, summarising or evaluating the application’s content

Expert reviewers and panellists must also:

comply with relevant intellectual property and data protection legislation

not take into account or speculate within their assessment whether generative AI has been used to develop the application

For more detail see our policy on the use of generative AI.

Sharing data with co-funders

We will need to share the application (including any personal information that it contains) with the Office for Life Sciences (OLS) so that they can participate in the assessment process.

Find out more information on how OLS uses personal information.

Sharing data with partners

We will need to share the application (including any personal information that it contains) with the Medicines and Healthcare products Regulatory Agency (MHRA) so they can participate in the assessment process and prepare to work with awardees.

Find out more information on how MHRA uses personal information.

We reserve the right to modify the assessment process as needed.

Assessment areas

The assessment areas we will use are:

vision

approach (including reproducibility, robustness and methodological design, where applicable, and data management)

leadership, governance and agility

capability of the applicant or applicants and the project team to deliver the project, including project partners

ethical and responsible research and innovation considerations of the project

resource justification and cost

Find details of assessment questions and criteria under the ‘Application questions’ heading in the ‘How to apply’ section.

Webinar for potential applicants

We will hold a webinar on 13 October 2026 at 10:00am UK time. This will provide more information about the funding opportunity and a chance to ask questions.

Register for the webinar

Eligibility

This opportunity is open to organisations based in the UK with standard eligibility. Check if your organisation is eligible

This funding opportunity is open to all eligible applicants and is not restricted to organisations or individuals that have previously received funding for a CERSI.

Who is eligible to apply

The nominated centre director (project lead) should lead the application, alongside a leadership team, and with the full support of their host research organisations.

To be eligible to apply for this funding opportunity you must:

be from a single eligible research organisation or a partnership of eligible organisations

have the relevant expertise and experience to lead or contribute to a CERSI and its research culture

show how you will strategically direct the CERSI and be actively engaged in the work

focus your application on one of the four CERSI strategic themes

For applicants who do not have a contract of employment for the duration of the proposed project, by submitting an application, the research organisation is confirming if it is successful:

contracts will be extended beyond the end date of the project

all necessary support for the project and the applicants will be provided, including mentorship and career development for early career researchers

Who is not eligible to apply

You are not eligible to apply for this funding opportunity as a project lead if you are based at an international research organisation.

This also includes project leads from MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine (LSHTM) or MRC/UVRI (Uganda Virus Research Institute) and LSHTM Uganda Research Unit.

If you are employed by any of the following organisations you cannot apply as project lead or project co-lead, but can participate as project partners on an application led by an eligible UK organisation:

businesses

charity and third sector organisations

However, charities and third sector organisations that are approved UK Research and Innovation (UKRI) independent research organisations are eligible to apply as project lead or project co-lead.

International researchers

As MRC is a lead funder for this funding opportunity, international researchers can apply as ‘project co-lead (international)’.

Project co-leads (international) make a major intellectual contribution to the design or conduct of the project. Their contribution and added value to the research should be clearly explained and justified in the application, …

Applying for grants? Grants Pro e-mails you every morning with the new grants and opened forecasts that match your saved searches, and adds deadline reminders in your calendar, a private RSS feed and CSV export. Try it free for 7 days, then $9/month, cancel any time. See what Pro does →

Applying? Read how to write a winning grant proposal.

Contains public sector information licensed under the Open Government Licence v3.0 (Find a grant). Last checked 19 Nov 2026. Always read the official page before applying: it has the full conditions, documents and how to apply.

Similar grants

Gambling harms research grants (Grant)

UK Research and Innovation, Arts and Humanities Research Council, Medical Research Council, Economic and Social Research Council, Biotechnology and Biological Sciences Research Council · UK · £1–£2m

Closes 8 Dec 2026 · 18 days left Most organisations

Condition Improvement Fund (CIF)

Department for Education · UK · £20k–£4m

Closes 15 Dec 2026 · 25 days left Nonprofits & charities Universities & schools Public bodies